TI
ELOS

Trexquant Investment’s Syneron Medical Ltd ELOS Stock Holding History

Trexquant Investment’s Portfolio ELOS Stock Details ELOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-27,984
Closed -$235K – 1481
2016
Q4 		$235K Buy
+27,984
New +$219K 0.04% 748

Other funds holding ELOS

BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
NTC
North Tide Capital Boston, Massachusetts $469M AUM 6.57% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
DGHMC
Dalton, Greiner, Hartman, Maher & Co New York $126M AUM 92.88% 1-Year Est. Return
DGI
Discovery Group I Chicago, Illinois $262M AUM 29.24% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Trexquant Investment's ELOS Position: Q1 2017 in Review

Trexquant Investment sold out of Syneron Medical Ltd (ELOS) in Q1 2017, closing a stake of 27,984 shares — an estimated $235K sold.

Trexquant Investment first reported a position in ELOS in Q4 2016 and held it in 1 quarter. The position peaked at $235K in Q4 2016. 91 funds tracked by Wall St. Rank hold ELOS as of Q1 2017.

  • Trexquant Investment reported no remaining Syneron Medical Ltd position as of Q1 2017 after selling out during the quarter.
  • Trexquant Investment sold 27,984 Syneron Medical Ltd shares in Q1 2017, an estimated $235K.
  • Trexquant Investment first reported a position in Syneron Medical Ltd in Q4 2016 and held it in 1 quarter.
  • Trexquant Investment's Syneron Medical Ltd position peaked at $235K in Q4 2016.
  • 91 funds tracked by Wall St. Rank held Syneron Medical Ltd as of Q1 2017.

Based on Trexquant Investment's 13F filing for Q1 2017, filed 9 May 2017.